Spanish drug development company working on new molecules for conditions with no effective therapy, including spinal cord injury, post-COVID fatigue and certain symptoms of Parkinson's disease, running its programmes jointly with Pharmaceutical Innovation Services.
暂无评论。
留下您的评分和评论